The Latest Breaking News from Alzheimer Disease

Around 55 million people, globally, have dementia – the most common type being Alzheimer’s disease. Unfortunately, there is no cure for the memory-robbing disease. But a lot of hope was pinned on an experimental drug called gantenerumab.

The actor told Vanity Fair the discovery he is at high risk is his ‘biggest fear’ but said: ‘It’s not like I’ve been handed my resignation’

Research Checks interrogate newly published studies and how they’re reported in the media. The analysis is undertaken by one or more academics not involved with the study, and reviewed by another, to make sure it’s accurate.

India Globalization Capital, Inc. (AMEX:IGC) reported its second fiscal quarter 2023 financial results, revealing revenue of $202,000, a 261% increase compared to $56,000 in the same quarter of 2022.

Some habits are seemingly innocent, but some are not only disgusting but could also cause you to unwittingly raise your risk of certain diseases. Case in point: picking your nose

A group of neuroscience researchers think Alzheimer's is an autoimmune condition — could this lead to a cure?

In 1906, Alois Alzheimer, a psychiatrist and neuroanatomist, reported “a peculiar severe disease process of the cerebral cortex” to a gathering of psychiatrists in Tübingen, Germany. The case was a 50-year-old woman who suffered from memory loss, delusions, hallucinations, aggression and confusion – all of which worsened until her untimely…

People who are prescribed the drug will need regular MRI scans to check for brain swelling or bleeding

Lecanemab is the first drug to help improve the symptoms of Alzheimer’s by slowing the disease. These are very promising results, although the only data we have at the moment is from the drugmaker’s press release.